MedTrace Logo

Adenosin to Rapidly Reverse Left Ventricle Impairment in Takotsubo Syndrome

NCT02867878 · Status: TERMINATED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 5

Last updated 2018-10-23

No results posted yet for this study

Summary

The investigators will randomize patients admitted to hospital with Takotsubo diagnosis to systematic high-dose adenosine infusion for 3 minutes (in addition to standard of care) vs. standard of care. The primary aim of the study is to demonstrate that adenosine infusion is associated with a larger and more rapid recovery of left ventricle function.

Conditions

  • Takotsubo Cardiomyopathy
  • Takotsubo Syndrome

Interventions

DRUG

Adenosine

DRUG

Saline solution

Sponsors & Collaborators

  • University Hospital of Ferrara

    lead OTHER

Principal Investigators

  • Matteo Tebaldi, MD · Azienda Ospedaliera Universitria di Ferrara

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-08-31
Primary Completion
2018-10-31
Completion
2018-10-31

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02867878 on ClinicalTrials.gov